Issues
-
Cover Image
Cover Image
ON THE COVER
Niclosamide, an anthelmintic medication, binds to a putative extracellular binding site on the TMEM16A calcium-activated chloride channel, enhancing its activation under physiological conditions. Image © Liang et al., 2024. See https://doi.org/10.1085/jgp.202313460. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research News
The S1 helix is a VIP in VSP
JGP study shows that hydrophobic residues in the S1 transmembrane domain modulate the voltage-sensor movements and enzymatic activity of voltage-sensing phosphatase.
Articles
Hydrophobic residues in S1 modulate enzymatic function and voltage sensing in voltage-sensing phosphatase
Rayaprolu et al. investigated how hydrophobic residues impact the function of the voltage-sensing phosphatase. They mutated different positions in the S1 helix of the voltage-sensing domain and found more energy was needed for enzyme activation while less was needed to move the sensor.
Carboxyl-group compounds activate voltage-gated potassium channels via a distinct mechanism
In a screen of 10,000 compounds, Ronnelid and Elinder found that carboxyl-group–containing compounds are potent activators of voltage-gated potassium channels. They suggest that lipophilic and charged compounds electrostatically activate the channel by binding close to the channel’s voltage sensor.
Niclosamide potentiates TMEM16A and induces vasoconstriction
Niclosamide, a proposed TMEM16A inhibitor for asthma and COPD, unexpectedly enhances TMEM16A activity, raising caution for its clinical use. Discovering its binding site on TMEM16A aids in developing targeted modulators for various diseases.
Email alerts
Most Read
Advertisement